Matches in SemOpenAlex for { <https://semopenalex.org/work/W2019752434> ?p ?o ?g. }
- W2019752434 endingPage "566" @default.
- W2019752434 startingPage "562" @default.
- W2019752434 abstract "Surveillance after orchiectomy alone becomes popular for the management of clinical stage I nonseminomatous germ cell testicular tumours (CS I NSGCTT). Effort to identify patients at high risk of relapse leads to searching prognostic factors of CS I NSGCTT. The aim of this study was to identify those patients in whom a surveillance policy is less likely to be successful.Seventy-two CS I NSGCTT patients were stratified to different risk-adapted therapeutic approaches according to histopathologic findings of primary tumor removed by inguinal orchiectomy. Eighteen patients (group A) with vascular invasion and majority of embryonal carcinoma component in the primary tumor were treated with adjuvant BEP chemotherapy. None of them experienced disease progression after a median follow-up period of 36 months after orchiectomy. Five patients (group B) with vascular invasion and the majority of teratomatous elements in the primary tumor have been followed up 56 months after orchiectomy. They were treated with primary retroperitoneal lymph node dissection (RPLND). Two of them (40%) had pathologic stage II after RPLND and underwent subsequent chemotherapy. One of them died due to disease progression 29 months following orchiectomy. Another one lives with no evidence of disease (NED). Three patients in pathologic stage I are alive with NED. Forth-nine patients (group C) without vascular invasion have been followed up for a median duration of 37 months after orchiectomy. They were kept under close surveillance, consisted of regular follow-up with tumor markers, chest x-ray and CT of the retroperitoneum. Disease progression was observed in 7 (14.3%) patients after a median duration of 8 months after orchiectomy. They were treated with BEP chemotherapy and live with disease-free median survival of 22 months after completion of therapy. The overall survival rate of all 72 patients was 98.6%. The median survival for all patients was 37 months (range 7-73).The authors will continue to use surveillance policy only in patients without vascular invasion in the primary tumor." @default.
- W2019752434 created "2016-06-24" @default.
- W2019752434 creator A5013430759 @default.
- W2019752434 creator A5016594552 @default.
- W2019752434 creator A5068724310 @default.
- W2019752434 creator A5070124068 @default.
- W2019752434 creator A5079546446 @default.
- W2019752434 creator A5049030215 @default.
- W2019752434 date "1998-01-01" @default.
- W2019752434 modified "2023-10-18" @default.
- W2019752434 title "Prognostic Factors in Clinical Stage I Nonseminomatous GermCell Testicular Tumors: Rationale for Different Risk-Adapted Treatment" @default.
- W2019752434 cites W1772146444 @default.
- W2019752434 cites W1866911875 @default.
- W2019752434 cites W1996357713 @default.
- W2019752434 cites W2006260220 @default.
- W2019752434 cites W2023104616 @default.
- W2019752434 cites W2024275464 @default.
- W2019752434 cites W2032368895 @default.
- W2019752434 cites W2033866752 @default.
- W2019752434 cites W2060372099 @default.
- W2019752434 cites W2062608898 @default.
- W2019752434 cites W2083870227 @default.
- W2019752434 cites W2162639940 @default.
- W2019752434 cites W2224031282 @default.
- W2019752434 cites W2226054732 @default.
- W2019752434 cites W2253544365 @default.
- W2019752434 cites W2267995930 @default.
- W2019752434 cites W2402561100 @default.
- W2019752434 cites W2411690360 @default.
- W2019752434 cites W2414912272 @default.
- W2019752434 cites W2416546922 @default.
- W2019752434 cites W2467424047 @default.
- W2019752434 cites W2885516198 @default.
- W2019752434 cites W3041047318 @default.
- W2019752434 cites W1798055509 @default.
- W2019752434 doi "https://doi.org/10.1159/000019656" @default.
- W2019752434 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/9743698" @default.
- W2019752434 hasPublicationYear "1998" @default.
- W2019752434 type Work @default.
- W2019752434 sameAs 2019752434 @default.
- W2019752434 citedByCount "58" @default.
- W2019752434 countsByYear W20197524342012 @default.
- W2019752434 countsByYear W20197524342013 @default.
- W2019752434 countsByYear W20197524342014 @default.
- W2019752434 countsByYear W20197524342015 @default.
- W2019752434 countsByYear W20197524342016 @default.
- W2019752434 countsByYear W20197524342017 @default.
- W2019752434 countsByYear W20197524342019 @default.
- W2019752434 countsByYear W20197524342021 @default.
- W2019752434 crossrefType "journal-article" @default.
- W2019752434 hasAuthorship W2019752434A5013430759 @default.
- W2019752434 hasAuthorship W2019752434A5016594552 @default.
- W2019752434 hasAuthorship W2019752434A5049030215 @default.
- W2019752434 hasAuthorship W2019752434A5068724310 @default.
- W2019752434 hasAuthorship W2019752434A5070124068 @default.
- W2019752434 hasAuthorship W2019752434A5079546446 @default.
- W2019752434 hasConcept C126322002 @default.
- W2019752434 hasConcept C126838900 @default.
- W2019752434 hasConcept C141071460 @default.
- W2019752434 hasConcept C143998085 @default.
- W2019752434 hasConcept C146357865 @default.
- W2019752434 hasConcept C151730666 @default.
- W2019752434 hasConcept C2775862295 @default.
- W2019752434 hasConcept C2776212926 @default.
- W2019752434 hasConcept C2776694085 @default.
- W2019752434 hasConcept C2776938808 @default.
- W2019752434 hasConcept C2779511695 @default.
- W2019752434 hasConcept C2780849966 @default.
- W2019752434 hasConcept C2781440318 @default.
- W2019752434 hasConcept C71924100 @default.
- W2019752434 hasConcept C86803240 @default.
- W2019752434 hasConceptScore W2019752434C126322002 @default.
- W2019752434 hasConceptScore W2019752434C126838900 @default.
- W2019752434 hasConceptScore W2019752434C141071460 @default.
- W2019752434 hasConceptScore W2019752434C143998085 @default.
- W2019752434 hasConceptScore W2019752434C146357865 @default.
- W2019752434 hasConceptScore W2019752434C151730666 @default.
- W2019752434 hasConceptScore W2019752434C2775862295 @default.
- W2019752434 hasConceptScore W2019752434C2776212926 @default.
- W2019752434 hasConceptScore W2019752434C2776694085 @default.
- W2019752434 hasConceptScore W2019752434C2776938808 @default.
- W2019752434 hasConceptScore W2019752434C2779511695 @default.
- W2019752434 hasConceptScore W2019752434C2780849966 @default.
- W2019752434 hasConceptScore W2019752434C2781440318 @default.
- W2019752434 hasConceptScore W2019752434C71924100 @default.
- W2019752434 hasConceptScore W2019752434C86803240 @default.
- W2019752434 hasIssue "6" @default.
- W2019752434 hasLocation W20197524341 @default.
- W2019752434 hasLocation W20197524342 @default.
- W2019752434 hasOpenAccess W2019752434 @default.
- W2019752434 hasPrimaryLocation W20197524341 @default.
- W2019752434 hasRelatedWork W101130268 @default.
- W2019752434 hasRelatedWork W1968716231 @default.
- W2019752434 hasRelatedWork W2080603030 @default.
- W2019752434 hasRelatedWork W2111751851 @default.
- W2019752434 hasRelatedWork W2136047808 @default.
- W2019752434 hasRelatedWork W2604231407 @default.
- W2019752434 hasRelatedWork W3021246602 @default.